tradingkey.logo
tradingkey.logo
Buscar

Solventum Corp

SOLV
Añadir a la lista de seguimiento
79.530USD
+1.610+2.07%
Cierre 06/26, 16:00ETCotizaciones retrasadas 15 min
13.77BCap. mercado
9.67P/E TTM

Más Datos de Solventum Corp Compañía

Solventum Corporation is a global healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer needs. The Company’s segments include MedSurg, Dental Solutions, and Health Information System. MedSurg is a provider of solutions including negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies Original Equipment Manufacturer (OEM). Dental Solutions is a provider of a comprehensive suite of dental and orthodontic products including brackets, aligners, and restorative cement. Health Information Systems provides healthcare systems with software solutions, including computer-assisted physician documentation, and direct-to-bill and coding automation.

Información de Solventum Corp

Símbolo de cotizaciónSOLV
Nombre de la empresaSolventum Corp
Fecha de salida a bolsaMar 26, 2024
Director ejecutivoHanson (Bryan C)
Número de empleados22000
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 26
DirecciónC/O 3M Company
CiudadST. PAUL
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal55144-1000
Teléfono16517331110
Sitio Webhttps://www.solventum.com/en-us/home/
Símbolo de cotizaciónSOLV
Fecha de salida a bolsaMar 26, 2024
Director ejecutivoHanson (Bryan C)

Ejecutivos de Solventum Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Wayde D. McMillan
Mr. Wayde D. McMillan
Chief Financial Officer
Chief Financial Officer
48.64K
+10.48%
Ms. Amy Landucci
Ms. Amy Landucci
Chief Information and Digital Officer
Chief Information and Digital Officer
39.89K
+6.03%
Mr. Paul S. Harrington
Mr. Paul S. Harrington
Chief Supply Chain Officer
Chief Supply Chain Officer
20.45K
+11.16%
Ms. Tammy L. Gomez
Ms. Tammy L. Gomez
Chief Human Resources Officer
Chief Human Resources Officer
13.36K
+17.15%
Mr. Chris Barry
Mr. Chris Barry
Executive Vice President and Group President, Medical Surgical
Executive Vice President and Group President, Medical Surgical
9.21K
+49.77%
Mr. Carlos Alban
Mr. Carlos Alban
Independent Director
Independent Director
8.95K
+38.04%
Mr. Glenn A. Eisenberg
Mr. Glenn A. Eisenberg
Independent Director
Independent Director
8.95K
+38.04%
Ms. Karen J. May, CPA
Ms. Karen J. May, CPA
Independent Director
Independent Director
8.95K
+38.04%
Mr. John H. Weiland
Mr. John H. Weiland
Independent Director
Independent Director
8.95K
+38.04%
Mr. Darryl L. Wilson
Mr. Darryl L. Wilson
Independent Director
Independent Director
8.95K
+38.04%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Wayde D. McMillan
Mr. Wayde D. McMillan
Chief Financial Officer
Chief Financial Officer
48.64K
+10.48%
Ms. Amy Landucci
Ms. Amy Landucci
Chief Information and Digital Officer
Chief Information and Digital Officer
39.89K
+6.03%
Mr. Paul S. Harrington
Mr. Paul S. Harrington
Chief Supply Chain Officer
Chief Supply Chain Officer
20.45K
+11.16%
Ms. Tammy L. Gomez
Ms. Tammy L. Gomez
Chief Human Resources Officer
Chief Human Resources Officer
13.36K
+17.15%
Mr. Chris Barry
Mr. Chris Barry
Executive Vice President and Group President, Medical Surgical
Executive Vice President and Group President, Medical Surgical
9.21K
+49.77%
Mr. Carlos Alban
Mr. Carlos Alban
Independent Director
Independent Director
8.95K
+38.04%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Solventum Corp?

Los cinco principales accionistas de Solventum Corp son: Mr. Wayde D. McMillan

¿Cuántas instituciones poseen acciones de Solventum Corp (SOLV)?

A fecha de 2026Q1, 1825 instituciones poseen acciones de Solventum Corp, con un valor de mercado combinado de aproximadamente 129.24M, lo que representa el 74.63% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -6936666.00.
KeyAI